Clinical trial
Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
NCT00331500 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00331500 |
|---|---|
| Title | Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis |
| Official title | A Comparative Study of Olopatadine 0.2% Versus Vehicle in Patients With Seasonal Allergic Conjunctivitis or Rhinoconjunctivitis |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Allergic Conjunctivitis |
| Intervention type | Drug |
| Interventions | Olopatadine Hydrochloride Ophthalmic Solution, 0.2%, Olopatadine Hydrochloride Ophthalmic Solution Vehicle |
| Enrollment | 287 |
| Start date | Apr 18, 2006 |
| Primary completion | Jul 27, 2006 |
| Completion | Jul 27, 2006 |
| First posted | May 31, 2006 |
| Last update posted | Aug 14, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: